Literature DB >> 9215263

Topical triclosan treatment of atopic dermatitis.

R Sporik, A S Kemp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9215263     DOI： 10.1016/s0091-6749(97)80029-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

Review 1.  [Systemic therapy of atopic dermatitis].

Authors:  A Heratizadeh; K Breuer; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

Review 2.  Childhood atopic eczema.

Authors:  Ross St C Barnetson; Maureen Rogers
Journal:  BMJ       Date:  2002-06-08

3.  Triclosan disrupts immune cell function by depressing Ca2+ influx following acidification of the cytoplasm.

Authors:  Suraj Sangroula; Alan Y Baez Vasquez; Prakash Raut; Bright Obeng; Juyoung K Shim; Grace D Bagley; Bailey E West; John E Burnell; Marissa S Kinney; Christian M Potts; Sasha R Weller; Joshua B Kelley; Samuel T Hess; Julie A Gosse
Journal:  Toxicol Appl Pharmacol       Date:  2020-08-21       Impact factor: 4.219

4.  A microplate assay to assess chemical effects on RBL-2H3 mast cell degranulation: effects of triclosan without use of an organic solvent.

Authors:  Lisa M Weatherly; Rachel H Kennedy; Juyoung Shim; Julie A Gosse
Journal:  J Vis Exp       Date:  2013-11-01       Impact factor: 1.355

Review 5.  Triclosan in water, implications for human and environmental health.

Authors:  L W B Olaniyan; N Mkwetshana; A I Okoh
Journal:  Springerplus       Date:  2016-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.